Browse/Search Our Legal Case Studies Library
Pharmacist Accused of Not Providing Medication Warnings for Anti-Depressant, Results in Patient Suicide
Claims Made Against Prescribing Physician and Pharmacy Claim Lack of Information Regarding Risk of Suicide With Use of Paxil - Man Commits Suicide Four Days After Starting Paxil - Defense Verdict.
The plaintiff’s decedent, age fifty, was prescribed the anti-depressant drug Paxil by the defendant physician in March 2007. Four days after he started taking the Paxil the decedent committed suicide at his home. The plaintiff claimed that the defendant physician was negligent in failing to properly warn of the drug’s side effects, failure to properly monitor the decedent and failure to properly treat the decedent.
The plaintiff claimed that the pharmacy was negligent in failing to warn of Paxil’s side effects. The plaintiff additionally claimed that the company (which provided the “Patient Counseling Information Form” received at the pharmacy) was negligent in providing false and misleading written information in the “Patient Counseling Information Form” provided with the prescription. This company was ultimately dismissed from the matter.
The plaintiff claimed that the decedent experienced a radical change in mood and behavior, including agitation, pacing, anxiety and insomnia after starting on Paxil. The plaintiff claimed that the drug caused akathisia, a highly agitated sense of inner restlessness which led to the suicide. The plaintiff claimed that she had called the defendant physician about the decedent’s behavior and mood, but the calls had not been returned.
The plaintiff claimed that the pharmacy should have provided the decedent with an FDA-mandated “Medication Guide” regarding suicide risks and failed to provide an oral consultation from a pharmacist regarding adverse effects of the newly prescribed medications.
The defendant physician admitted that no suicide warnings were given regarding Paxil, but maintained that none were required because there was no evidence of an increased risk of suicidal thoughts/acts for persons in the decedent’s age group.
The pharmacy claimed that the decedent was provided with all required warnings and that warning stickers, including a suicide warning, had been removed from the bottle after it was dispensed. The defendants both claimed that the suicide was due to the decedent’s undiagnosed health problem and was not related to Paxil.
According to a published account a defense verdict was returned.
With permission from Medical Malpractice Verdicts, Settlements & Experts; Lewis Laska, Editor, 901 Church St., Nashville, TN 37203-3411, 1-800-298-6288.
This publication is intended to inform Affinity Insurance Services, Inc., customers of potential liability in their practice. This information is provided for general informational purposes only and is not intended to provide individualized guidance. All descriptions, summaries or highlights of coverage are for general informational purposes only and do not amend, alter or modify the actual terms or conditions of any insurance policy. Coverage is governed only by the terms and conditions of the relevant policy. This information is not intended to offer legal advice or to establish appropriate or acceptable standards of professional conduct. Readers should consult with a lawyer if they have specific concerns. Neither Affinity Insurance Services, Inc., HPSO, nor CNA assumes any liability for how this information is applied in practice or for the accuracy of this information.
Healthcare Providers Service Organization is a registered trade name of Affinity Insurance Services, Inc., a licensed producer in all states (TX 13695); (AR 100106022); in CA, MN, AIS Affinity Insurance Agency, Inc. (CA 0795465); in OK, AIS Affinity Insurance Services, Inc.; in CA, Aon Affinity Insurance Services, Inc., (CA 0G94493), Aon Direct Insurance Administrators and Berkely Insurance Agency and in NY, AIS Affinity Insurance Agency.